| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Aselage Steve is a Director at Travere Therapeutics, Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 13 sells.
Estimated insider holdings value: $8.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 15, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 5,549 | $26.02 | $144,384.98 | -2.7% | |
| Dec 2, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 7,891 | $23.43 | $184,849.04 | -3.8% | |
| Nov 6, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 23,125 | $22.81 | $527,525.00 | -4.9% | |
| Aug 5, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 2,500 | $19.68 | $49,200.00 | -1.0% | |
| Jun 25, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 10,000 | $20.00 | $200,000.00 | -4.0% | |
| May 14, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 8,125 | $16.00 | $130,039.41 | -1.1% | |
| May 5, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 2,500 | $15.88 | $39,700.00 | -1.0% | |
| Mar 5, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 4,359 | $15.36 | $66,938.55 | -1.7% | |
| Feb 5, 2020 | TVTX Travere Therapeutics, Inc. | Director | Sell | 2,500 | $16.62 | $41,550.00 | -1.0% | |
| Nov 29, 2019 | TVTX Travere Therapeutics, Inc. | Director | Sell | 5,000 | $13.91 | $69,552.50 | -2.0% |